Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication

Virology

Volumn 309, Issue 2, 2003, Pages 294-305

  Abujamra, Ana L ^a   Faller, Douglas V ^a   Ghosh, Sajal K ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Collagenase IV; Feline leukemia virus; FeLV; LTR; MCP 1; Transactivation

Indexed keywords

COLLAGENASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; ENZYME ASSAY; FELINE LEUKEMIA VIRUS; LONG TERMINAL REPEAT; MOLECULAR CLONING; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; VIRUS MUTATION; VIRUS REPLICATION;

FELIDAE; FELINE LEUKEMIA VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; MURINE LEUKEMIA VIRUS;

EID: 0037903341     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00069-2     Document Type: Article

References (38)

1. Angel P., Hattori K., Smeal T., Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell. 55:(5):1988;875-885.
2. Athas G.B., Choi B., Prabhu S., Lobelle-Rich P.A., Levy L.S. Genetic determinants of feline leukemia virus-induced multicentric lymphomas. Virology. 214:(2):1995;431-438.
3. Athas G.B., Lobelle-Rich P., Levy L.S. Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally boccurring tumors. J. Virol. 69:(6):1995;3324-3332.
4. Bechtel M.K., Stallcup M.R., Bedgood R.M., Corey J.L., Pandey R., Roy-Burman P. Abnormal processing of a recombinant feline leukemia virus envelope polyprotein and its interference with subgroup C virus infection. Virology. 202:(1):1994;329-338.
5. Chatis P.A., Holland C.A., Silver J.E., Frederickson T.N., Hopkins N., Hartley J.W. A 3′ end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney Leukemia virus. J. Virol. 52:1984;248-254.
6. Chen H., Bechtel M.K., Shi Y., Phipps A., Mathes L.E., Hayes K.A., Roy-Burman P. Pathogenicity induced by feline leukemia virus, Rickard strain, subgroup A plasmid DNA (pFRA). J. Virol. 72:(9):1998;7048-7056.
7. Choi S.Y., Faller D.V. A transcript from the long terminal repeats of a murine retrovirus associated with trans activation of cellular genes. J. Virol. 69:(11):1995;7054-7060.
8. DesGroseillers L., Jolicoeur P. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J. Virol. 52:1984;945-952.
9. Donahue P.R., Hoover E.A., Beltz G.A., Riedel N., Hirsch V.M., Overbaugh J., Mullins J.I. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J. Virol. 62:(3):1988;722-731.
10. Faller D.V., Weng H., Choi S.Y. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat. Virology. 227:(2):1997;331-342.
11. Faller D.V., Weng H., Graves D.T., Choi S.Y. Moloney murine leukemia virus long terminal repeat activates monocyte chemotactic protein-1 protein expression and chemotactic activity. J. Cell. Physiol. 172:(2):1997;240-252.
12. Flyer D.C., Burakoff S.J., Faller D.V. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. J. Immunol. 135:(4):1985;2287-2292.
13. Ghosh S.K., Faller D.V. Feline leukemia virus long terminal repeat activates collagenase IV expression through AP-1. J. Virol. 73:(6):1999;4931-4940.
14. Ghosh S.K., Roy-Burman P., Faller D.V. Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression. J. Virol. 74:(20):2000;9742-9748.
15. Golemis E., Li Y., Fredrickson T.N., Hartley J.W., Hopkins N. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses. J. Virol. 63:(1):1989;328-337.
16. Gorman C.M., Moffat L.F., Howard B.H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
17. Hanecak R., Pattengale P.K., Fan H. Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus. J. Virol. 65:(10):1991;5357-5363.
18. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 77:(1):1989;51-59.
19. Hoover E.A., Mullins J.I. Feline leukemia virus infection and diseases. J. Am. Vet. Med. Assoc. 199:(10):1991;1287-1297.
20. Klement, V., Nicolson, M.O. 1977. Methods for assays of RNA tumor viruses, in: Methods in Virology, Academic Press, New York, Vol. 6, pp. 59-108.
21. Lenz J., Celander D., Crowther R.L., Patarca R., Perkins D.W., Haseltine W.A. Determination of the leukemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature. 308:1984;467-470.
22. Matsumoto Y., Momoi Y., Watari T., Goitsuka R., Tsujimoto H., Hasegawa A. Detection of enhancer repeats in the long terminal repeats of feline leukemia viruses from cats with spontaneous neoplastic and nonneoplastic diseases. Virology. 189:(2):1992;745-749.
23. Overbaugh J., Donahue P.R., Quackenbush S.L., Hoover E.A., Mullins J.I. Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science. 239:(4842):1988;906-910.
24. Pantginis J., Beaty R.M., Levy L.S., Lenz J. The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity. J. Virol. 71:(12):1997;9786-9791.
25. Rezanka L.J., Rojko J.L., Neil J.C. Feline leukemia virus pathogenesis of neoplastic disease . Cancer Invest. 10:(5):1992;371-389.
26. Rohn J.L., Moser M.S., Gwynn S.R., Baldwin D.N., Overbaugh J. In vivo evolution of novel, syncytium-inducing and cytopathic feline leukemia virus variant. J. Virol. 72:(4):1998;2686-2696.
27. Rohn J.L., Overbaugh J. In vivo selection of long terminal repeat alterations in feline leukemia virus-induced thymic lymphomas. Virology. 206:(1):1995;661-665.
28. Short M.K., Okenquist S.A., Lenz J. Correlation of leukemogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeats. J. Virol. 61:(4):1987;1067-1072.
29. Speck N.A., Renjifo B., Golemix E., Fredrickson T., Hartley J., Hopkins N. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4:1990;233-242.
30. Starkey C.R., Lobelle-Rich P.A., Granger S., Brightman B.K., Fan H., Levy L.S. Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus. J. Virol. 72:(2):1998;1078-1084.
31. Timmers H.T., Pronk G.J., Bos J.L., van der Eb A.J. Analysis of the rat JE gene promoter identifies an AP-1 binding site essential for basal expression but not for TPA induction. Nucleic Acids Res. 18:(1):1990;23-34.
32. Tupper J.C., Chen H., Hays E.F., Bristol G.C., Yoshimura F.K. Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer. J. Virol. 66:(12):1992;7080-7088.
33. Wei X., Ghosh S.K., Taylor M.E., Johnson V.A., Emini E.A., Deutsch P., Lifson J.D., Bonhoeffer S., Nowak M.A., Hahn B.H., Saag M.S., Shaw G.M. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:(6510):1995;117-122.
34. Wilson L.D., Flyer D.C., Faller D.V. Murine retroviruses control class I major histocompatibility antigen gene expression via a trans effect at the transcriptional level. Mol. Cell. Biol. 7:(7):1987;2406-2415.
35. Yoshimura F.K., Cankovic M., Smeltz R., Ibrahim S. Identification of nucleotide sequences that regulate transcription of the MCF13 murine leukemia virus long terminal repeat in activated T cells. J. Virol. 71:(3):1997;2572-2576.
36. Yoshimura F.K., Wang T., Cankovic M. Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus. J. Virol. 73:(6):1999;4890-4898.
37. Zaiman A.L., Lewis A.F., Crute B.E., Speck N.A., Lenz J. Transcriptional activity of core binding factor alpha (AML1) and beta subunits on murine leukemia virus enhancer cores. J. Virol. 69:(5):1995;2898-2906.
38. Zaiman A.L., Nieves A., Lenz J. CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes. J. Virol. 72:(4):1998;3129-3137.